These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12427339)

  • 21. Cross-protection between JMV Marek's disease-derived tumour transplant, Marek's disease and turkey herpesviruses.
    Bulow VV
    Avian Pathol; 1977; 6(4):353-66. PubMed ID: 18770345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens.
    Esaki M; Noland L; Eddins T; Godoy A; Saeki S; Saitoh S; Yasuda A; Dorsey KM
    Avian Dis; 2013 Jun; 57(2):192-8. PubMed ID: 24689173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional Analyses of Innate and Acquired Immune Patterning Elicited by Marek's Disease Virus Vaccine Strains: Turkey Herpesvirus (HVT), Marek's Disease Virus 2 (strain SB1), and Bivalent Vaccines (HVT/SB1 and HVT-LT/SB1).
    Neerukonda SN; Katneni UK; Bhandari N; Parcells MS
    Avian Dis; 2019 Dec; 63(4):670-680. PubMed ID: 31865682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of administration of probiotic lactobacilli on immunity conferred by the herpesvirus of turkeys vaccine against challenge with a very virulent Marek's disease virus in chickens.
    Bavananthasivam J; Alizadeh M; Astill J; Alqazlan N; Matsuyama-Kato A; Shojadoost B; Taha-Abdelaziz K; Sharif S
    Vaccine; 2021 Apr; 39(17):2424-2433. PubMed ID: 33781599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of the protocols for double vaccination against Marek's disease by using commercially available vaccines: evaluation of protection, vaccine replication, and activation of T cells.
    Gimeno IM; Cortes AL; Witter RL; Pandiri AR
    Avian Dis; 2012 Jun; 56(2):295-305. PubMed ID: 22856185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fletcher OJ; West M; Montiel E; Gimeno IM
    Avian Pathol; 2016 Dec; 45(6):606-615. PubMed ID: 27207594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
    Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
    Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, application, and results of routine monitoring of Marek's disease virus in broiler house dust using real-time quantitative PCR.
    Walkden-Brown SW; Islam AF; Groves PJ; Rubite A; Sharpe SM; Burgess SK
    Avian Dis; 2013 Jun; 57(2 Suppl):544-54. PubMed ID: 23901774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compatibility of turkey herpesvirus-infectious bursal disease vector vaccine with Marek's disease rispens vaccine injected into day-old pullets.
    Lemiere S; Wong SY; Saint-Gerand AL; Goutebroze S; Le Gros FX
    Avian Dis; 2011 Mar; 55(1):113-8. PubMed ID: 21500646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-viral immunity against Marek's disease virus infected chicken kidney cells.
    Kodama H; Sugimoto C; Inage F; Mikami T
    Avian Pathol; 1979 Jan; 8(1):33-44. PubMed ID: 18770425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.
    Li Y; Reddy K; Reid SM; Cox WJ; Brown IH; Britton P; Nair V; Iqbal M
    Vaccine; 2011 Oct; 29(46):8257-66. PubMed ID: 21907750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HVT Vaccination on Splenic miRNA Expression in Marek's Disease Virus Infections.
    Hicks JA; Liu HC
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30764490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Ovo Vaccination with Turkey Herpesvirus Hastens Maturation of Chicken Embryo Immune Responses in Specific-Pathogen-Free Chickens.
    Gimeno IM; Faiz NM; Cortes AL; Barbosa T; Villalobos T; Pandiri AR
    Avian Dis; 2015 Sep; 59(3):375-83. PubMed ID: 26478155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a new bivalent Marek's disease vaccine does not interfere with infectious bronchitis or Newcastle disease vaccinations and proves efficacious.
    Rahaus M; Augustinski K; Castells M; Desloges N
    Avian Dis; 2013 Jun; 57(2 Suppl):498-502. PubMed ID: 23901767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts.
    Schat KA
    Avian Dis; 2016 Dec; 60(4):715-724. PubMed ID: 27902902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative sequential study of viraemia and neutralising antibody to HVT and MDV in a commercial flock vaccinated with HVT.
    Biggs PM; Shilleto RW; Milne BS
    Avian Pathol; 1980 Oct; 9(4):511-23. PubMed ID: 18770292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
    PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T; Walkden Brown SW; Renz KG; Fakhrul Islam AF; Ralapanawe S
    Avian Pathol; 2013 Dec; 42(6):516-26. PubMed ID: 24098951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphology of immune organs after very virulent plus strain of Marek's disease virus infection in vaccinated hens.
    Madej JP; Woźniakowski G; Gaweł A
    Pol J Vet Sci; 2016; 19(2):325-35. PubMed ID: 27487506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.